Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) Is Getting Increasingly Hard To Ignore
Currently, there are 11.63M common shares owned by the public and among those 10.16M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
